Xcout Intel
CytoAgents, Inc.
CytoAgents, Inc. is a biotechnology company headquartered in Pittsburgh, Pennsylvania, dedicated to developing novel therapeutic solutions for immune-related conditions.
Subscribe to see CytoAgents, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
CytoAgents, Inc. at a glance
CytoAgents, Inc. is a company headquartered in United States. It has raised at least $13.1M across the 2 funding rounds on record. Its most recent funding round raised $7M in May 2023. Xcout tracks 8 named people at CytoAgents, Inc., including Teresa Whalen (Chief Executive Officer).
CytoAgents, Inc. leadership
- Teresa WhalenChief Executive Officer
- Roy PriebChief Financial Officer
- Denise GottfriedChief Regulatory and Operations Officer
- Michael HowellChief Science Officer
- Anthony McCarleyFounder & CEO of McCarley International
- Catherine V. MottFounder, CEO & Managing Partner Blue Tree Capital Group
2 more named people on record for CytoAgents, Inc., with roles, board committees and tenure — see the full roster →
CytoAgents, Inc. funding rounds
At least $13.1M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $7M | — | |
| SEC Form D filing | $6.1M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
CytoAgents, Inc. competitors
A few of CytoAgents, Inc.'s closest competitors — see the full list of competitors and alternatives →
Celsense, Inc. is a pharmaceutical and biotechnology company headquartered in Pittsburgh, Pennsylvania. The company develops novel products and tracer agents used in cellular imaging and cellular immunotherapy monitoring with magnetic resonance imaging (MRI).
BlueSphere Bio, Inc. is a biotechnology company headquartered in Pittsburgh, Pennsylvania, focused on advancing cellular therapies and oncology research.
MetasTx Inc. is a biotechnology company headquartered in Pittsburgh, Pennsylvania, focused on creating novel therapeutics to treat diseases.
LyGenesis Inc. is a clinical-stage biotechnology company headquartered in Pittsburgh, Pennsylvania. Founded in 2017, the firm is developing a novel cell therapy platform that leverages patient lymph nodes as bioreactors to regenerate failing organs.
Cytobyte, Inc. is a biotechnology company based in Cleveland, Ohio, involved in pharmaceutical and biotech developments.
CytoImmune Therapeutics, Inc. is a biotechnology company headquartered in Duarte, California, focused on the development of novel cancer immunotherapy treatments.
Get CytoAgents, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on CytoAgents, Inc. in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access